SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-21-018893
Filing Date
2021-08-06
Accepted
2021-08-06 16:35:47
Documents
2
Period of Report
2021-08-03

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2694
2 ex-24.htm EX-24 6461
  Complete submission text file 0001493152-21-018893.txt   10613
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 347-480-9760
Indaptus Therapeutics, Inc. (Issuer) CIK: 0001857044 (see all company filings)

IRS No.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INTEC PARENT, INC. 12 HARTOM ST., HAR HOTZVIM JERUSALEM L3 9777512
Business Address
Lee Hoonmo (Reporting) CIK: 0001875672 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40652 | Film No.: 211153416